Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

The nonprofit health system’s new partnership with the Mark Cuban Cost Plus Drug Co. marketplace for businesses officially goes into effect in January. The marketplace is part of Cuban’s larger ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Medicare beneficiaries who take a lot of pricey medications will get a big break come 2025. That’s when the $2,000 annual cap ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...

If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs would be available at cost plus 15%, and the amount of money spent on drugs would decline ...

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

Medicare beneficiaries who take a lot of pricey medications will get a big break in 2025. That’s when the $2,000 annual cap on out-of-pocket costs for drugs bought at the pharmacy or through ...